메뉴 건너뛰기




Volumn 15, Issue 1, 2012, Pages 77-86

Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: Results from a four-country survey

Author keywords

Diabetes; Disease management; Hypoglycemia; Productivity; Quality of life; Sleep

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

EID: 84856038752     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2011.624144     Document Type: Review
Times cited : (79)

References (23)
  • 1
    • 64749110344 scopus 로고    scopus 로고
    • Hypoglycemia: Still the limiting factor in the glycemic management of diabetes
    • Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract 2008;14:750-6
    • (2008) Endocr Pract , vol.14 , pp. 750-756
    • Cryer, P.E.1
  • 2
    • 33748366186 scopus 로고    scopus 로고
    • Hypoglycemia in type 1 and type 2 diabetes: Physiology, pathophysiology, and management
    • DOI 10.2337/diaclin.24.3.115
    • Briscoe V, Davis S. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clin Diabetes 2006;24:115-21 (Pubitemid 44338340)
    • (2006) Clinical Diabetes , vol.24 , Issue.3 , pp. 115-121
    • Briscoe, V.J.1    Davis, S.N.2
  • 4
    • 18144388647 scopus 로고    scopus 로고
    • Defining and reporting hypoglycemia in diabetes: A report from the american diabetes association workgroup on hypoglycemia
    • American Diabetes Association Workgroup on Hypoglycemia.
    • American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245-9
    • (2005) Diabetes Care , vol.28 , pp. 1245-1249
  • 5
    • 77952938468 scopus 로고    scopus 로고
    • Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes
    • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.
    • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care 2010;33:1004-8
    • (2010) Diabetes Care , vol.33 , pp. 1004-1008
  • 7
    • 33947704161 scopus 로고    scopus 로고
    • PREDICTIVE™ - A global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: Baseline characteristics and predictors of hypoglycaemia from the European cohort
    • DOI 10.1111/j.1463-1326.2006.00677.x
    • Luddeke HJ, Sreenan S, Aczel S, et al. PREDICTIVE-a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort. Diabetes Obes Metab 2007;9:428-34 (Pubitemid 46502063)
    • (2007) Diabetes, Obesity and Metabolism , vol.9 , Issue.3 , pp. 428-434
    • Luddeke, H.-J.1    Sreenan, S.2    Aczel, S.3    Maxeiner, S.4    Yenigun, M.5    Kozlovski, P.6    Gydesen, H.7    Dornhorst, A.8
  • 8
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK prospective diabetes study (UKPDS) group
    • UK Prospective Diabetes Study (UKPDS) Group.
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352: 837-53
    • (1998) Lancet , vol.352 , pp. 837-853
  • 10
    • 43449094999 scopus 로고    scopus 로고
    • Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in france
    • Vexiau P, Mavros P, Krishnarajah G, et al. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab 2008;10(1 Suppl):16-24
    • (2008) Diabetes Obes Metab , vol.10 , Issue.1 SUPPL. , pp. 16-24
    • Vexiau, P.1    Mavros, P.2    Krishnarajah, G.3
  • 12
    • 0026084950 scopus 로고
    • Symptomatic hypoglycaemia in 411 type 1 diabetic patients
    • Pramming S, Thorsteinsson B, Bendtson I, et al. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991;8:217-22
    • (1991) Diabet Med , vol.8 , pp. 217-222
    • Pramming, S.1    Thorsteinsson, B.2    Bendtson, I.3
  • 13
    • 80052455283 scopus 로고    scopus 로고
    • The impact of non-severe hypo-glycemic events on work productivity and diabetes management
    • Brod M, Christensen T, Thomson TL, et al. The impact of non-severe hypo-glycemic events on work productivity and diabetes management. Value Health 2011;14:665-71
    • (2011) Value Health , vol.14 , pp. 665-671
    • Brod, M.1    Christensen, T.2    Thomson, T.L.3
  • 14
    • 0041592733 scopus 로고    scopus 로고
    • Hypoglycemia in diabetes
    • DOI 10.2337/diacare.26.6.1902
    • Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-12 (Pubitemid 36929141)
    • (2003) Diabetes Care , vol.26 , Issue.6 , pp. 1902-1912
    • Cryer, P.E.1    Davis, S.N.2    Shamoon, H.3
  • 15
    • 72449165113 scopus 로고    scopus 로고
    • Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis
    • Davidson JA, Liebl A, Christiansen JS, et al. Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis. Clin Ther 2009; 31:1641-51
    • (2009) Clin Ther , vol.31 , pp. 1641-1651
    • Davidson, J.A.1    Liebl, A.2    Christiansen, J.S.3
  • 16
    • 1442310505 scopus 로고    scopus 로고
    • Nocturnal hypoglycemia: Clinical manifestations and therapeutic strategies toward prevention
    • Allen KV, Frier BM. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr Pract 2003;9:530-43
    • (2003) Endocr Pract , vol.9 , pp. 530-543
    • Allen, K.V.1    Frier, B.M.2
  • 17
    • 0029062779 scopus 로고
    • Nocturnal hypoglycaemia in patients with insulin-dependent diabetes mellitus
    • Bendtson I. Nocturnal hypoglycaemia in patients with insulin-dependent diabetes mellitus. Dan Med Bull 1995;42:269-84
    • (1995) Dan Med Bull , vol.42 , pp. 269-284
    • Bendtson, I.1
  • 18
    • 80053047636 scopus 로고    scopus 로고
    • How diabetes and insulin therapy affects the lives of people with type 1 diabetes
    • Nafees B, Lloyd A, Kennedy-Martin T, et al. How diabetes and insulin therapy affects the lives of people with type 1 diabetes. Eur Diabetes Nursing 2006; 3:92-7
    • (2006) Eur Diabetes Nursing , vol.3 , pp. 92-97
    • Nafees, B.1    Lloyd, A.2    Kennedy-Martin, T.3
  • 19
    • 0242516067 scopus 로고    scopus 로고
    • Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: Reduced awakening from sleep during hypoglycemia
    • DOI 10.2337/diabetes.52.5.1195
    • Banarer S, Cryer PE. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes 2003;52:1195-203 (Pubitemid 36523356)
    • (2003) Diabetes , vol.52 , Issue.5 , pp. 1195-1203
    • Banarer, S.1    Cryer, P.E.2
  • 20
    • 0031935612 scopus 로고    scopus 로고
    • Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM
    • DOI 10.2337/diacare.21.3.341
    • King P, Kong MF, Parkin H, et al. Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. Diabetes Care 1998;21:341-5 (Pubitemid 28101066)
    • (1998) Diabetes Care , vol.21 , Issue.3 , pp. 341-345
    • King, P.1    Kong, M.-F.2    Parkin, H.3    Macdonald, I.A.4    Tattersall, R.B.5
  • 21
    • 66249118999 scopus 로고    scopus 로고
    • Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: The ISPOR patient-reported outcomes translation and linguistic validation good research practices task force report
    • Wild D, Eremenco S, Mear I, et al. Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR patient-reported outcomes translation and linguistic validation good research practices task force report. Value Health 2009;12:430-40
    • (2009) Value Health , vol.12 , pp. 430-440
    • Wild, D.1    Eremenco, S.2    Mear, I.3
  • 23
    • 84856025095 scopus 로고    scopus 로고
    • The World Factbook Washington, D.C.: Central Intelligence Agency Available at Accessed March 22, 2010
    • The World Factbook. Europe: United Kingdom. Washington, D.C.: Central Intelligence Agency, 2009; Available at: https://www.cia.gov/library/ publications/the-world-factbook/geos/uk.html. Accessed March 22, 2010
    • (2009) Europe: United Kingdom


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.